Clinical Trials Directory

Trials / Unknown

UnknownNCT04691245

3D US Guided Femoral Artery Access for TAVI

Three Dimensional Ultrasound Guided Femoral Access for Transcatheter Aortic Valve Implantation

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
104 (estimated)
Sponsor
Catharina Ziekenhuis Eindhoven · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Rationale: Bleeding and vascular complications of the femoral artery still account for significant morbidity and mortality in transcatheter aortic valve implantation procedures. Although steadily declining over the past years through smaller diameter devices and use of ultrasound, major complications still occur in 3-4 % of patients. Femoral access is often obtained using 2D US guidance already. New 3D US probes can aid in increasing anatomical awareness. This can improve first pass success during procedures. Furthermore, for new closure devices, entering the artery at a straight angle at precisely 12 o'clock probably reduces complications. Therefore, the investigators hypothesize improved real time needle guidance using three dimensional ultrasound can decrease procedure related complications.

Conditions

Interventions

TypeNameDescription
DEVICE3D US3D US guided access to femoral artery
DEVICE2D US2D US guided access to femoral artery

Timeline

Start date
2021-02-01
Primary completion
2021-09-01
Completion
2021-12-01
First posted
2020-12-31
Last updated
2020-12-31

Locations

1 site across 1 country: Netherlands

Regulatory

Source: ClinicalTrials.gov record NCT04691245. Inclusion in this directory is not an endorsement.